Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Feasibility Trial of Stereotactic Re-irradiation of Prostate Cancer Recurrence Within the Definitively Irradiated Prostate

NCT03073278 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.

NCT NCT03073278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03073278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Feasibility Trial of Stereotactic Re-irradiation of Prostate Cancer Recurrence Within the Definitively Irradiated Prostate
Lead sponsor
Royal North Shore Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 24, 2017
Completion date
March 31, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

locally recurrent prostate cancer